Bibliography
- Alberti A , BenvegnuL: Management of hepatitis C.J. Hepatol.38, S104–S118 (2003).
- Fried MW , PeterJ, HootsK et al.: Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon α-2b and ribavirin.Hepatology36, 967–972 (2002).
- Hu KQ , VierlingJM, RedekerAG: Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.J. Viral Hepat.8(1), 1–18 (2001).
- Lai MY , KaoJH, YangPM et al.: Long-term efficacy of ribavirin plus interferon α in the treatment of chronic hepatitis C.Gastroenterology111, 1307–1312 (1996).
- Lauer GM , WalkerBD: Hepatitis C virus infection.N. Engl. J. Med.345, 41–52 (2001).
- Manns MP , McHutchisonJG, GordonSC et al.: Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial.Lancet358, 958–965 (2001).
- Fried MW , ShiffmanML, ReddyKR et al.: Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection.N. Engl. J. Med.347, 975–982 (2002).
- Ferenci P : Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies.J. Antimicrob. Chemother.53, 15–18 (2004).
- Collier J , ChapmanR: Combination therapy with interferon-α and ribavirin for hepatitis C: practical treatment issues.BioDrugs15(4), 225–238 (2001).
- Martinot-Peignoux M , MarcellinP, Pouteau MP et al.: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon α therapy in chronic hepatitis C. Hepatology22, 1050–1056 (1995).
- Fried MW , HoofnagleJH: Therapy of hepatitis C.Semin. Liver Dis.15, 82–91 (1995).
- Yee LJ , TangJ, GibsonAW, KimberlyR, van Leeuwen DJ, Kaslow RA: Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology33(3), 708–712 (2001).
- Hijikata M , OhtaY, MishiroS: Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt-88) correlated with the response of hepatitis C patients to interferon.Intervirology43(2), 124–127 (2000).
- Sugimoto Y , KuzushitaN, TakeharaT et al.: A single nucleotide polymorphism of the low molecular mass polypeptide 7 gene influences the interferon response in patients with chronic hepatitis C.J. Viral Hepat.9(5), 377–384 (2002).
- Hwang Y , ChenEY, GuZJ et al.: Genetic predisposition of responsiveness to therapy for chronic hepatitis C.Pharmacogenomics7(5), 697–709 (2006).
- Lin E , HwangY, WangSC, GuZJ, Chen EY: An artificial neural network approach to the drug efficacy of interferon treatments. Pharmacogenomics7(7), 1017–1024 (2006).
- Bell JT , WallaceC, DobsonR et al.: Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension.Hum. Mol. Genet.15, 1365–1374 (2006).
- Carlborg O , HaleyCS: Epistasis: too often neglected in complex trait studies.Nature5, 618–625 (2004).
- Lin E , HwangY, LiangKH, ChenEY: pattern-recognition techniques with haplotype analysis in pharmacogenomics.Pharmacogenomics8(1), 75–83 (2007).
- Kessler HH , SantnerB, UmlauftF et al.: Detection of hepatitis C viral sequences in serum by 'nested‘ polymerase chain reaction (PCR) and a commercial single-round PCR assay.Clin. Diagn. Virol.4, 239–250 (1995).
- Pawlotsky JM : Use and interpretation of virological tests for hepatitis C.Hepatology36, S65–S73 (2002)
- Simmonds P : Variability of hepatitis C virus.Hepatology21, 570–583 (1995)
- Lin E , HwangY, TzengCM: A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.Mol. Diagn. Ther.10(6), 367–370 (2006).
- Kung SY , HwangJN: Neural networks for intelligent multimedia processing.Proc. IEEE86, 1244–1272 (1998).
- Rumelhart DE , HintonGE, WilliamRJ: Learning internal representation by error propagation. In:Parallel Distributed Processing: Explorations in the Micro-Structure of Cognition, vol.1, Foundations. MIT Press, MA, USA (1996).
- Neural Network Toolbox for use with MATLAB. The Mathworks Inc., Natick MA 01760–1500, USA (1998).
- Nestorov I , HadjitodorovST, PetrovI, RowlandM: Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates.AAPS PharmSci.1(4), 17 (1999).
- Hastie T , TibshiraniR, FriedmanJH: The Elements of Statistical Learning. Springer-Verlag, NY, USA (2001).
- Bishop CM : Neural Networks for Pattern Recognition. Clarendon Press, NY, USA (1995).
- Hirschhorn JN , DalyMI: Genome-wide association studies for common diseases and complex traits.Nature Review Genet.6, 95–108 (2005).
- North BV , CurtisD, CassellPG, Hitman GA, Sham PC: Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Nat. Rev. Genet.67348–6356 (2003).
- Jensen DM , MorganTR, MarcellinP et al.: Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy.Hepatology43(5), 954–960 (2006).
- van Soest H , BolandGJ, van Erpecum KJ. Hepatitis C: changing genotype distribution with important implications for patient management. Neth. J. Med.64(4), 96–99 (2006).
- Maiellaro PA , CozzolongoR, MarinoP: Artificial neural networks for the prediction of response to interferon plus ribavirin treatment in patients with chronic hepatitis C.Curr. Pharm. Des.10(17), 2101–2109 (2004).
- Ma DQ , WhiteheadPL, MenoldMM et al.: Identification of significant association and gene–gene interaction of GABA receptor subunit genes in autism.Am. J. Hum. Genet.77(3), 377–388 (2005).
- Ritchie MD , MotsingerAA: Multifactor dimensionality reduction for detecting gene–gene and gene–environment interactions in pharmacogenomics studies.Pharmacogenomics6(8), 823–834 (2005).
- Erb RJ : Introduction to backpropagation neural network computation.Pharm Res.10, 165–170 (1993).
- Kitamura A , TakahashiK, OkajimaA, KitamuraN: Induction of the human gene for p44, a hepatitis C-associated microtubular aggregate protein, by interferon-α/β.Eur. J. Biochem.224, 877–883 (1994).
- Davis GL , WongJB, McHutchisonJG, MannsMP, HarveyJ, AlbrechtJ: Early virologic response to treatment with peginterferon α-2b plus ribavirin in patients with chronic hepatitis C.Hepatology38, 645–652 (2003).
- Raptopoulou M , TsantoulasD, VafiadiI et al.: The effect of adherence to therapy on sustained response in daily or three times a week interferon α-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients. J. Viral Hepat.12, 91–95 (2005).
- Bacon BR , McHutchisonJG: Treatment issues with chronic hepatitis C: special populations and pharmacy strategies.Am. J. Manag. Care11, S296–S306 (2005).